Clinical Trial Update: Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients

View source ↗

Summary

A clinical trial aiming to assess disease activity in apparently stable patients with neuromyelitis optica spectrum disorder to anticipate irreversible disabili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Neuromyelitis Optica Spectrum Disorders | Status: NOT_YET_RECRUITING